- call +1-201-465-4211
- email sales@mrinsights.biz
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Scope of the Report:
This report focuses on the Bronchodilators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
North America is expected to be the largest market for bronchodilators due to high incidence rate of diseases such as COPD and asthma, high demand for bronchodilator drugs, and increase in awareness. Europe holds the second largest market share. The Asia Pacific market is expected to provide a lucrative opportunity during the forecast period due to increasing disease burden, growing biopharmaceutical industry, and rising research activity along with competitive landscape in the pharmaceutical industry. The market in Latin America and Middle East & Africa is anticipated to grow owing to increasing health care infrastructure and growing public-private collaboration to expand the health care sector.
The worldwide market for Bronchodilators is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines
Market Segment by Applications, can be divided into
Asthma
COPD
Others
There are 15 Chapters to deeply display the global Bronchodilators market.
Chapter 1, to describe Bronchodilators Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bronchodilators, with sales, revenue, and price of Bronchodilators, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bronchodilators, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bronchodilators market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bronchodilators sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bronchodilators Introduction
1.2 Market Analysis by Type
1.2.1 Anticholinergic Bronchodilators
1.2.2 Adrenergic Bronchodilators
1.2.3 Bronchodilator Combinations
1.2.4 Methylxanthines
1.3 Market Analysis by Applications
1.3.1 Asthma
1.3.2 COPD
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Bronchodilators Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Bronchodilators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Bronchodilators Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Bronchodilators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Bronchodilators Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Bronchodilators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche
2.4.1 Business Overview
2.4.2 Bronchodilators Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Bronchodilators Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bronchodilators Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bronchodilators Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bronchodilators Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bronchodilators Manufacturer Market Share in 2017
3.3.2 Top 6 Bronchodilators Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bronchodilators Market Analysis by Regions
4.1 Global Bronchodilators Sales, Revenue and Market Share by Regions
4.1.1 Global Bronchodilators Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bronchodilators Revenue and Market Share by Regions (2013-2018)
4.2 North America Bronchodilators Sales and Growth Rate (2013-2018)
4.3 Europe Bronchodilators Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bronchodilators Sales and Growth Rate (2013-2018)
4.5 South America Bronchodilators Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bronchodilators Sales and Growth Rate (2013-2018)
5 North America Bronchodilators by Countries
5.1 North America Bronchodilators Sales, Revenue and Market Share by Countries
5.1.1 North America Bronchodilators Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bronchodilators Revenue and Market Share by Countries (2013-2018)
5.2 United States Bronchodilators Sales and Growth Rate (2013-2018)
5.3 Canada Bronchodilators Sales and Growth Rate (2013-2018)
5.4 Mexico Bronchodilators Sales and Growth Rate (2013-2018)
6 Europe Bronchodilators by Countries
6.1 Europe Bronchodilators Sales, Revenue and Market Share by Countries
6.1.1 Europe Bronchodilators Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bronchodilators Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bronchodilators Sales and Growth Rate (2013-2018)
6.3 UK Bronchodilators Sales and Growth Rate (2013-2018)
6.4 France Bronchodilators Sales and Growth Rate (2013-2018)
6.5 Russia Bronchodilators Sales and Growth Rate (2013-2018)
6.6 Italy Bronchodilators Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bronchodilators by Countries
7.1 Asia-Pacific Bronchodilators Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bronchodilators Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bronchodilators Revenue and Market Share by Countries (2013-2018)
7.2 China Bronchodilators Sales and Growth Rate (2013-2018)
7.3 Japan Bronchodilators Sales and Growth Rate (2013-2018)
7.4 Korea Bronchodilators Sales and Growth Rate (2013-2018)
7.5 India Bronchodilators Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bronchodilators Sales and Growth Rate (2013-2018)
8 South America Bronchodilators by Countries
8.1 South America Bronchodilators Sales, Revenue and Market Share by Countries
8.1.1 South America Bronchodilators Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bronchodilators Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bronchodilators Sales and Growth Rate (2013-2018)
8.3 Argentina Bronchodilators Sales and Growth Rate (2013-2018)
8.4 Colombia Bronchodilators Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bronchodilators by Countries
9.1 Middle East and Africa Bronchodilators Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bronchodilators Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bronchodilators Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bronchodilators Sales and Growth Rate (2013-2018)
9.3 UAE Bronchodilators Sales and Growth Rate (2013-2018)
9.4 Egypt Bronchodilators Sales and Growth Rate (2013-2018)
9.5 Nigeria Bronchodilators Sales and Growth Rate (2013-2018)
9.6 South Africa Bronchodilators Sales and Growth Rate (2013-2018)
10 Global Bronchodilators Market Segment by Type
10.1 Global Bronchodilators Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bronchodilators Sales and Market Share by Type (2013-2018)
10.1.2 Global Bronchodilators Revenue and Market Share by Type (2013-2018)
10.2 Anticholinergic Bronchodilators Sales Growth and Price
10.2.1 Global Anticholinergic Bronchodilators Sales Growth (2013-2018)
10.2.2 Global Anticholinergic Bronchodilators Price (2013-2018)
10.3 Adrenergic Bronchodilators Sales Growth and Price
10.3.1 Global Adrenergic Bronchodilators Sales Growth (2013-2018)
10.3.2 Global Adrenergic Bronchodilators Price (2013-2018)
10.4 Bronchodilator Combinations Sales Growth and Price
10.4.1 Global Bronchodilator Combinations Sales Growth (2013-2018)
10.4.2 Global Bronchodilator Combinations Price (2013-2018)
10.5 Methylxanthines Sales Growth and Price
10.5.1 Global Methylxanthines Sales Growth (2013-2018)
10.5.2 Global Methylxanthines Price (2013-2018)
11 Global Bronchodilators Market Segment by Application
11.1 Global Bronchodilators Sales Market Share by Application (2013-2018)
11.2 Asthma Sales Growth (2013-2018)
11.3 COPD Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Bronchodilators Market Forecast (2018-2023)
12.1 Global Bronchodilators Sales, Revenue and Growth Rate (2018-2023)
12.2 Bronchodilators Market Forecast by Regions (2018-2023)
12.2.1 North America Bronchodilators Market Forecast (2018-2023)
12.2.2 Europe Bronchodilators Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bronchodilators Market Forecast (2018-2023)
12.2.4 South America Bronchodilators Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bronchodilators Market Forecast (2018-2023)
12.3 Bronchodilators Market Forecast by Type (2018-2023)
12.3.1 Global Bronchodilators Sales Forecast by Type (2018-2023)
12.3.2 Global Bronchodilators Market Share Forecast by Type (2018-2023)
12.4 Bronchodilators Market Forecast by Application (2018-2023)
12.4.1 Global Bronchodilators Sales Forecast by Application (2018-2023)
12.4.2 Global Bronchodilators Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bronchodilators Picture
Table Product Specifications of Bronchodilators
Figure Global Sales Market Share of Bronchodilators by Types in 2017
Table Bronc
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
